Listed

Definitive Healthcare Corp.

DHNasdaqCIK 1861795TechnologyFiscal year ends Dec 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$55.2m, Q2 FY2026
Operating income−$6.7m, Q2 FY2026
Net income−$5.4m, Q2 FY2026
Definitive Healthcare Corp., income statement, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$m65.3Revenue, Q3 FY2023, three months to 2023-09-30$65.3m. XBRL concept us-gaap:Revenues. 10-Q filed 2024-11-07, accession 0000950170-24-123385.Report this figure65.9Revenue, Q4 FY2023, three months to 2023-12-31$65.9m. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-26, accession 0001193125-26-076782. Derived: 12-month figure less the 9-month figure.Report this figure63.5Revenue, Q1 FY2024, three months to 2024-03-31$63.5m. XBRL concept us-gaap:Revenues. 10-Q filed 2025-05-08, accession 0000950170-25-067044.Report this figure63.7Revenue, Q2 FY2024, three months to 2024-06-30$63.7m. XBRL concept us-gaap:Revenues. 10-Q filed 2025-08-07, accession 0000950170-25-105071.Report this figure62.7Revenue, Q3 FY2024, three months to 2024-09-30$62.7m. XBRL concept us-gaap:Revenues. 10-Q filed 2025-11-06, accession 0001193125-25-269681.Report this figure62.3Revenue, Q4 FY2024, three months to 2024-12-31$62.3m. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-26, accession 0001193125-26-076782. Derived: 12-month figure less the 9-month figure.Report this figure59.2Revenue, Q1 FY2025, three months to 2025-03-31$59.2m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-05-07, accession 0001193125-26-212063.Report this figure60.8Revenue, Q2 FY2025, three months to 2025-06-30$60.8m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-10, accession 0001193125-26-342488.Report this figure60.0Revenue, Q3 FY2025, three months to 2025-09-30$60.0m. XBRL concept us-gaap:Revenues. 10-Q filed 2025-11-06, accession 0001193125-25-269681.Report this figure61.5Revenue, Q4 FY2025, three months to 2025-12-31$61.5m. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-26, accession 0001193125-26-076782. Derived: 12-month figure less the 9-month figure.Report this figure55.9Revenue, Q1 FY2026, three months to 2026-03-31$55.9m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-05-07, accession 0001193125-26-212063.Report this figure55.2Revenue, Q2 FY2026, three months to 2026-06-30$55.2m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-10, accession 0001193125-26-342488.Report this figure
Cost of revenue$mnot reportednot reported13.1Cost of revenue, Q1 FY2024, three months to 2024-03-31$13.1m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2025-05-08, accession 0000950170-25-067044.Report this figure13.3Cost of revenue, Q2 FY2024, three months to 2024-06-30$13.3m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2025-08-07, accession 0000950170-25-105071.Report this figure13.7Cost of revenue, Q3 FY2024, three months to 2024-09-30$13.7m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2025-11-06, accession 0001193125-25-269681.Report this figure14.7Cost of revenue, Q4 FY2024, three months to 2024-12-31$14.7m. XBRL concept us-gaap:CostOfRevenue. 10-K filed 2026-02-26, accession 0001193125-26-076782. Derived: 12-month figure less the 9-month figure.Report this figure15.4Cost of revenue, Q1 FY2025, three months to 2025-03-31$15.4m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2026-05-07, accession 0001193125-26-212063.Report this figure14.1Cost of revenue, Q2 FY2025, three months to 2025-06-30$14.1m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2026-08-10, accession 0001193125-26-342488.Report this figure14.1Cost of revenue, Q3 FY2025, three months to 2025-09-30$14.1m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2025-11-06, accession 0001193125-25-269681.Report this figure14.6Cost of revenue, Q4 FY2025, three months to 2025-12-31$14.6m. XBRL concept us-gaap:CostOfRevenue. 10-K filed 2026-02-26, accession 0001193125-26-076782. Derived: 12-month figure less the 9-month figure.Report this figure14.3Cost of revenue, Q1 FY2026, three months to 2026-03-31$14.3m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2026-05-07, accession 0001193125-26-212063.Report this figure14.7Cost of revenue, Q2 FY2026, three months to 2026-06-30$14.7m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2026-08-10, accession 0001193125-26-342488.Report this figure
Gross profit$m53.4Gross profit, Q3 FY2023, three months to 2023-09-30$53.4m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2024-11-07, accession 0000950170-24-123385.Report this figure53.4Gross profit, Q4 FY2023, three months to 2023-12-31$53.4m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-02-26, accession 0001193125-26-076782. Derived: 12-month figure less the 9-month figure.Report this figure50.4Gross profit, Q1 FY2024, three months to 2024-03-31$50.4m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-05-08, accession 0000950170-25-067044.Report this figure50.5Gross profit, Q2 FY2024, three months to 2024-06-30$50.5m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-08-07, accession 0000950170-25-105071.Report this figure49.0Gross profit, Q3 FY2024, three months to 2024-09-30$49.0m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-11-06, accession 0001193125-25-269681.Report this figure47.6Gross profit, Q4 FY2024, three months to 2024-12-31$47.6m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-02-26, accession 0001193125-26-076782. Derived: 12-month figure less the 9-month figure.Report this figure43.8Gross profit, Q1 FY2025, three months to 2025-03-31$43.8m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-05-07, accession 0001193125-26-212063.Report this figure46.6Gross profit, Q2 FY2025, three months to 2025-06-30$46.6m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-10, accession 0001193125-26-342488.Report this figure46.0Gross profit, Q3 FY2025, three months to 2025-09-30$46.0m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-11-06, accession 0001193125-25-269681.Report this figure46.9Gross profit, Q4 FY2025, three months to 2025-12-31$46.9m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-02-26, accession 0001193125-26-076782. Derived: 12-month figure less the 9-month figure.Report this figure41.7Gross profit, Q1 FY2026, three months to 2026-03-31$41.6m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-05-07, accession 0001193125-26-212063.Report this figure40.5Gross profit, Q2 FY2026, three months to 2026-06-30$40.5m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-10, accession 0001193125-26-342488.Report this figure
Research and development$m10.8Research and development, Q3 FY2023, three months to 2023-09-30$10.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-07, accession 0000950170-24-123385.Report this figure11.6Research and development, Q4 FY2023, three months to 2023-12-31$11.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-02-26, accession 0001193125-26-076782. Derived: 12-month figure less the 9-month figure.Report this figure10.1Research and development, Q1 FY2024, three months to 2024-03-31$10.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-08, accession 0000950170-25-067044.Report this figure10.1Research and development, Q2 FY2024, three months to 2024-06-30$10.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-07, accession 0000950170-25-105071.Report this figure7.3Research and development, Q3 FY2024, three months to 2024-09-30$7.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-06, accession 0001193125-25-269681.Report this figure9.0Research and development, Q4 FY2024, three months to 2024-12-31$9.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-02-26, accession 0001193125-26-076782. Derived: 12-month figure less the 9-month figure.Report this figure9.3Research and development, Q1 FY2025, three months to 2025-03-31$9.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-07, accession 0001193125-26-212063.Report this figure8.0Research and development, Q2 FY2025, three months to 2025-06-30$8.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-10, accession 0001193125-26-342488.Report this figure7.6Research and development, Q3 FY2025, three months to 2025-09-30$7.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-06, accession 0001193125-25-269681.Report this figure10.0Research and development, Q4 FY2025, three months to 2025-12-31$10.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-02-26, accession 0001193125-26-076782. Derived: 12-month figure less the 9-month figure.Report this figure6.5Research and development, Q1 FY2026, three months to 2026-03-31$6.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-07, accession 0001193125-26-212063.Report this figure6.8Research and development, Q2 FY2026, three months to 2026-06-30$6.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-10, accession 0001193125-26-342488.Report this figure
Operating income$m(295)Operating income, Q3 FY2023, three months to 2023-09-30−$295.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-07, accession 0000950170-24-123385.Report this figure(10.1)Operating income, Q4 FY2023, three months to 2023-12-31−$10.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-26, accession 0001193125-26-076782. Derived: 12-month figure less the 9-month figure.Report this figure(16.2)Operating income, Q1 FY2024, three months to 2024-03-31−$16.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-08, accession 0000950170-25-067044.Report this figure(370)Operating income, Q2 FY2024, three months to 2024-06-30−$369.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-07, accession 0000950170-25-105071.Report this figure(225)Operating income, Q3 FY2024, three months to 2024-09-30−$225.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-06, accession 0001193125-25-269681.Report this figure(99.6)Operating income, Q4 FY2024, three months to 2024-12-31−$99.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-26, accession 0001193125-26-076782. Derived: 12-month figure less the 9-month figure.Report this figure(185)Operating income, Q1 FY2025, three months to 2025-03-31−$184.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-07, accession 0001193125-26-212063.Report this figure(4.2)Operating income, Q2 FY2025, three months to 2025-06-30−$4.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-10, accession 0001193125-26-342488.Report this figure(8.7)Operating income, Q3 FY2025, three months to 2025-09-30−$8.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-06, accession 0001193125-25-269681.Report this figure(26.6)Operating income, Q4 FY2025, three months to 2025-12-31−$26.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-26, accession 0001193125-26-076782. Derived: 12-month figure less the 9-month figure.Report this figure(201)Operating income, Q1 FY2026, three months to 2026-03-31−$201.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-07, accession 0001193125-26-212063.Report this figure(6.7)Operating income, Q2 FY2026, three months to 2026-06-30−$6.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-10, accession 0001193125-26-342488.Report this figure
Interest expense$m3.9Interest expense, Q3 FY2023, three months to 2023-09-30$3.9m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2024-11-07, accession 0000950170-24-123385.Report this figure3.9Interest expense, Q4 FY2023, three months to 2023-12-31$3.9m. XBRL concept us-gaap:InterestExpense. 10-K filed 2026-02-26, accession 0001193125-26-076782. Derived: 12-month figure less the 9-month figure.Report this figure3.8Interest expense, Q1 FY2024, three months to 2024-03-31$3.8m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2025-05-08, accession 0000950170-25-067044.Report this figure3.8Interest expense, Q2 FY2024, three months to 2024-06-30$3.8m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2025-08-07, accession 0000950170-25-105071.Report this figure3.7Interest expense, Q3 FY2024, three months to 2024-09-30$3.7m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2025-11-06, accession 0001193125-25-269681.Report this figure3.5Interest expense, Q4 FY2024, three months to 2024-12-31$3.5m. XBRL concept us-gaap:InterestExpense. 10-K filed 2026-02-26, accession 0001193125-26-076782. Derived: 12-month figure less the 9-month figure.Report this figure2.4Interest expense, Q1 FY2025, three months to 2025-03-31$2.4m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2026-05-07, accession 0001193125-26-212063.Report this figure3.0Interest expense, Q2 FY2025, three months to 2025-06-30$3.0m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2026-08-10, accession 0001193125-26-342488.Report this figure3.0Interest expense, Q3 FY2025, three months to 2025-09-30$3.0m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2025-11-06, accession 0001193125-25-269681.Report this figure2.9Interest expense, Q4 FY2025, three months to 2025-12-31$2.9m. XBRL concept us-gaap:InterestExpense. 10-K filed 2026-02-26, accession 0001193125-26-076782. Derived: 12-month figure less the 9-month figure.Report this figure2.6Interest expense, Q1 FY2026, three months to 2026-03-31$2.6m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2026-05-07, accession 0001193125-26-212063.Report this figure2.6Interest expense, Q2 FY2026, three months to 2026-06-30$2.6m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2026-08-10, accession 0001193125-26-342488.Report this figure
Income tax$m(17.5)Income tax, Q3 FY2023, three months to 2023-09-30−$17.5m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2024-11-07, accession 0000950170-24-123385.Report this figure1.2Income tax, Q4 FY2023, three months to 2023-12-31$1.2m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-26, accession 0001193125-26-076782. Derived: 12-month figure less the 9-month figure.Report this figure(0.8)Income tax, Q1 FY2024, three months to 2024-03-31−$780.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-05-08, accession 0000950170-25-067044.Report this figure(21.9)Income tax, Q2 FY2024, three months to 2024-06-30−$21.9m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-08-07, accession 0000950170-25-105071.Report this figure(13.7)Income tax, Q3 FY2024, three months to 2024-09-30−$13.7m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-06, accession 0001193125-25-269681.Report this figure(5.9)Income tax, Q4 FY2024, three months to 2024-12-31−$5.9m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-26, accession 0001193125-26-076782. Derived: 12-month figure less the 9-month figure.Report this figure(10.9)Income tax, Q1 FY2025, three months to 2025-03-31−$10.9m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-07, accession 0001193125-26-212063.Report this figure0.5Income tax, Q2 FY2025, three months to 2025-06-30$456.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-10, accession 0001193125-26-342488.Report this figure0.5Income tax, Q3 FY2025, three months to 2025-09-30$524.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-06, accession 0001193125-25-269681.Report this figure(0.1)Income tax, Q4 FY2025, three months to 2025-12-31−$53.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-26, accession 0001193125-26-076782. Derived: 12-month figure less the 9-month figure.Report this figure(3.4)Income tax, Q1 FY2026, three months to 2026-03-31−$3.4m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-07, accession 0001193125-26-212063.Report this figure(0.3)Income tax, Q2 FY2026, three months to 2026-06-30−$345.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-10, accession 0001193125-26-342488.Report this figure
Net income$m(172)Net income, Q3 FY2023, three months to 2023-09-30−$171.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-07, accession 0000950170-24-123385.Report this figure(10.2)Net income, Q4 FY2023, three months to 2023-12-31−$10.2m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-26, accession 0001193125-26-076782. Derived: 12-month figure less the 9-month figure.Report this figure(9.5)Net income, Q1 FY2024, three months to 2024-03-31−$9.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-05-08, accession 0000950170-25-067044.Report this figure(214)Net income, Q2 FY2024, three months to 2024-06-30−$213.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-08-07, accession 0000950170-25-105071.Report this figure(131)Net income, Q3 FY2024, three months to 2024-09-30−$130.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-06, accession 0001193125-25-269681.Report this figure(59.1)Net income, Q4 FY2024, three months to 2024-12-31−$59.1m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-26, accession 0001193125-26-076782. Derived: 12-month figure less the 9-month figure.Report this figure(107)Net income, Q1 FY2025, three months to 2025-03-31−$107.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-07, accession 0001193125-26-212063.Report this figure(7.6)Net income, Q2 FY2025, three months to 2025-06-30−$7.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-10, accession 0001193125-26-342488.Report this figure(14.8)Net income, Q3 FY2025, three months to 2025-09-30−$14.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-06, accession 0001193125-25-269681.Report this figure(9.3)Net income, Q4 FY2025, three months to 2025-12-31−$9.3m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-26, accession 0001193125-26-076782. Derived: 12-month figure less the 9-month figure.Report this figure(139)Net income, Q1 FY2026, three months to 2026-03-31−$138.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-07, accession 0001193125-26-212063.Report this figure(5.4)Net income, Q2 FY2026, three months to 2026-06-30−$5.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-10, accession 0001193125-26-342488.Report this figure
Diluted EPS$ per share(1.50)Diluted EPS, Q3 FY2023, three months to 2023-09-30−$1.50 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-07, accession 0000950170-24-123385.Report this figurenot reported(0.08)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$0.08 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-08, accession 0000950170-25-067044.Report this figure(1.81)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$1.81 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-07, accession 0000950170-25-105071.Report this figure(1.12)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$1.12 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-06, accession 0001193125-25-269681.Report this figurenot reported(0.95)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$0.95 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-07, accession 0001193125-26-212063.Report this figure(0.07)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$0.07 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-10, accession 0001193125-26-342488.Report this figure(0.14)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$0.14 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-06, accession 0001193125-25-269681.Report this figurenot reported(1.32)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$1.32 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-07, accession 0001193125-26-212063.Report this figure(0.05)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.05 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-10, accession 0001193125-26-342488.Report this figure
Basic EPS$ per share(1.50)Basic EPS, Q3 FY2023, three months to 2023-09-30−$1.50 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-07, accession 0000950170-24-123385.Report this figurenot reported(0.08)Basic EPS, Q1 FY2024, three months to 2024-03-31−$0.08 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-08, accession 0000950170-25-067044.Report this figure(1.81)Basic EPS, Q2 FY2024, three months to 2024-06-30−$1.81 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-07, accession 0000950170-25-105071.Report this figure(1.12)Basic EPS, Q3 FY2024, three months to 2024-09-30−$1.12 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-06, accession 0001193125-25-269681.Report this figurenot reported(0.95)Basic EPS, Q1 FY2025, three months to 2025-03-31−$0.95 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-07, accession 0001193125-26-212063.Report this figure(0.07)Basic EPS, Q2 FY2025, three months to 2025-06-30−$0.07 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-10, accession 0001193125-26-342488.Report this figure(0.14)Basic EPS, Q3 FY2025, three months to 2025-09-30−$0.14 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-06, accession 0001193125-25-269681.Report this figurenot reported(1.32)Basic EPS, Q1 FY2026, three months to 2026-03-31−$1.32 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-07, accession 0001193125-26-212063.Report this figure(0.05)Basic EPS, Q2 FY2026, three months to 2026-06-30−$0.05 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-10, accession 0001193125-26-342488.Report this figure

Balance sheet

Cash and equivalents$170.9m, Q2 FY2026
Long-term debt$151.9m, Q2 FY2026
Shareholders' equity$187.9m, Q2 FY2026
Definitive Healthcare Corp., balance sheet, quarterly
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m77.5Cash and equivalents, Q3 FY2023, at 2023-09-30$77.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2023-11-02, accession 0000950170-23-058257.Report this figure131Cash and equivalents, FY2023, at 2023-12-31$131.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-02-27, accession 0000950170-25-029086.Report this figure106Cash and equivalents, Q1 FY2024, at 2024-03-31$106.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-05-07, accession 0000950170-24-054539.Report this figure121Cash and equivalents, Q2 FY2024, at 2024-06-30$120.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-08-05, accession 0000950170-24-090808.Report this figure138Cash and equivalents, Q3 FY2024, at 2024-09-30$137.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-07, accession 0000950170-24-123385.Report this figure105Cash and equivalents, FY2024, at 2024-12-31$105.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-02-26, accession 0001193125-26-076782.Report this figure106Cash and equivalents, Q1 FY2025, at 2025-03-31$106.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-08, accession 0000950170-25-067044.Report this figure81.0Cash and equivalents, Q2 FY2025, at 2025-06-30$81.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-07, accession 0000950170-25-105071.Report this figure108Cash and equivalents, Q3 FY2025, at 2025-09-30$108.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-06, accession 0001193125-25-269681.Report this figure164Cash and equivalents, FY2025, at 2025-12-31$163.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-10, accession 0001193125-26-342488.Report this figure158Cash and equivalents, Q1 FY2026, at 2026-03-31$157.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-07, accession 0001193125-26-212063.Report this figure171Cash and equivalents, Q2 FY2026, at 2026-06-30$170.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-10, accession 0001193125-26-342488.Report this figure
Current assets$m375Current assets, Q3 FY2023, at 2023-09-30$375.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-02, accession 0000950170-23-058257.Report this figure394Current assets, FY2023, at 2023-12-31$393.9m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-02-27, accession 0000950170-25-029086.Report this figure379Current assets, Q1 FY2024, at 2024-03-31$378.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-07, accession 0000950170-24-054539.Report this figure368Current assets, Q2 FY2024, at 2024-06-30$368.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-05, accession 0000950170-24-090808.Report this figure369Current assets, Q3 FY2024, at 2024-09-30$368.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-07, accession 0000950170-24-123385.Report this figure370Current assets, FY2024, at 2024-12-31$370.2m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-02-26, accession 0001193125-26-076782.Report this figure273Current assets, Q1 FY2025, at 2025-03-31$273.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-08, accession 0000950170-25-067044.Report this figure249Current assets, Q2 FY2025, at 2025-06-30$249.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-07, accession 0000950170-25-105071.Report this figure246Current assets, Q3 FY2025, at 2025-09-30$246.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-06, accession 0001193125-25-269681.Report this figure258Current assets, FY2025, at 2025-12-31$257.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-10, accession 0001193125-26-342488.Report this figure246Current assets, Q1 FY2026, at 2026-03-31$245.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-07, accession 0001193125-26-212063.Report this figure240Current assets, Q2 FY2026, at 2026-06-30$240.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-10, accession 0001193125-26-342488.Report this figure
Total assets$m1,820Total assets, Q3 FY2023, at 2023-09-30$1.82bn. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-02, accession 0000950170-23-058257.Report this figure1,826Total assets, FY2023, at 2023-12-31$1.83bn. XBRL concept us-gaap:Assets. 10-K filed 2025-02-27, accession 0000950170-25-029086.Report this figure1,810Total assets, Q1 FY2024, at 2024-03-31$1.81bn. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-07, accession 0000950170-24-054539.Report this figure1,422Total assets, Q2 FY2024, at 2024-06-30$1.42bn. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-05, accession 0000950170-24-090808.Report this figure1,182Total assets, Q3 FY2024, at 2024-09-30$1.18bn. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-07, accession 0000950170-24-123385.Report this figure1,089Total assets, FY2024, at 2024-12-31$1.09bn. XBRL concept us-gaap:Assets. 10-K filed 2026-02-26, accession 0001193125-26-076782.Report this figure809Total assets, Q1 FY2025, at 2025-03-31$808.7m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-08, accession 0000950170-25-067044.Report this figure770Total assets, Q2 FY2025, at 2025-06-30$770.1m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-07, accession 0000950170-25-105071.Report this figure756Total assets, Q3 FY2025, at 2025-09-30$755.5m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-06, accession 0001193125-25-269681.Report this figure735Total assets, FY2025, at 2025-12-31$735.5m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-10, accession 0001193125-26-342488.Report this figure515Total assets, Q1 FY2026, at 2026-03-31$514.7m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-07, accession 0001193125-26-212063.Report this figure497Total assets, Q2 FY2026, at 2026-06-30$496.8m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-10, accession 0001193125-26-342488.Report this figure
Current liabilities$m147Current liabilities, Q3 FY2023, at 2023-09-30$147.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-02, accession 0000950170-23-058257.Report this figure171Current liabilities, FY2023, at 2023-12-31$170.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-02-27, accession 0000950170-25-029086.Report this figure165Current liabilities, Q1 FY2024, at 2024-03-31$165.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-07, accession 0000950170-24-054539.Report this figure153Current liabilities, Q2 FY2024, at 2024-06-30$153.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-05, accession 0000950170-24-090808.Report this figure148Current liabilities, Q3 FY2024, at 2024-09-30$148.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-07, accession 0000950170-24-123385.Report this figure161Current liabilities, FY2024, at 2024-12-31$161.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-02-26, accession 0001193125-26-076782.Report this figure156Current liabilities, Q1 FY2025, at 2025-03-31$156.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-08, accession 0000950170-25-067044.Report this figure151Current liabilities, Q2 FY2025, at 2025-06-30$151.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-07, accession 0000950170-25-105071.Report this figure154Current liabilities, Q3 FY2025, at 2025-09-30$153.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-06, accession 0001193125-25-269681.Report this figure157Current liabilities, FY2025, at 2025-12-31$156.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-10, accession 0001193125-26-342488.Report this figure140Current liabilities, Q1 FY2026, at 2026-03-31$140.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-07, accession 0001193125-26-212063.Report this figure129Current liabilities, Q2 FY2026, at 2026-06-30$129.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-10, accession 0001193125-26-342488.Report this figure
Total liabilities$m616Total liabilities, Q3 FY2023, at 2023-09-30$616.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-02, accession 0000950170-23-058257.Report this figure627Total liabilities, FY2023, at 2023-12-31$626.7m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-02-27, accession 0000950170-25-029086.Report this figure615Total liabilities, Q1 FY2024, at 2024-03-31$615.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-07, accession 0000950170-24-054539.Report this figure536Total liabilities, Q2 FY2024, at 2024-06-30$536.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-05, accession 0000950170-24-090808.Report this figure486Total liabilities, Q3 FY2024, at 2024-09-30$486.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-07, accession 0000950170-24-123385.Report this figure482Total liabilities, FY2024, at 2024-12-31$482.2m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-02-26, accession 0001193125-26-076782.Report this figure373Total liabilities, Q1 FY2025, at 2025-03-31$372.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-08, accession 0000950170-25-067044.Report this figure359Total liabilities, Q2 FY2025, at 2025-06-30$358.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-07, accession 0000950170-25-105071.Report this figure366Total liabilities, Q3 FY2025, at 2025-09-30$365.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-06, accession 0001193125-25-269681.Report this figure357Total liabilities, FY2025, at 2025-12-31$356.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-10, accession 0001193125-26-342488.Report this figure324Total liabilities, Q1 FY2026, at 2026-03-31$324.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-07, accession 0001193125-26-212063.Report this figure309Total liabilities, Q2 FY2026, at 2026-06-30$309.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-10, accession 0001193125-26-342488.Report this figure
Long-term debt$m246Long-term debt, Q3 FY2023, at 2023-09-30$245.9m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2023-11-02, accession 0000950170-23-058257.Report this figure243Long-term debt, FY2023, at 2023-12-31$242.6m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-K filed 2025-02-27, accession 0000950170-25-029086.Report this figure239Long-term debt, Q1 FY2024, at 2024-03-31$239.3m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2024-05-07, accession 0000950170-24-054539.Report this figure236Long-term debt, Q2 FY2024, at 2024-06-30$236.0m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2024-08-05, accession 0000950170-24-090808.Report this figure233Long-term debt, Q3 FY2024, at 2024-09-30$232.7m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2024-11-07, accession 0000950170-24-123385.Report this figure229Long-term debt, FY2024, at 2024-12-31$229.4m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-K filed 2026-02-26, accession 0001193125-26-076782.Report this figure162Long-term debt, Q1 FY2025, at 2025-03-31$162.4m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2025-05-08, accession 0000950170-25-067044.Report this figure160Long-term debt, Q2 FY2025, at 2025-06-30$160.3m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2025-08-07, accession 0000950170-25-105071.Report this figure158Long-term debt, Q3 FY2025, at 2025-09-30$158.2m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2025-11-06, accession 0001193125-25-269681.Report this figure156Long-term debt, FY2025, at 2025-12-31$156.1m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2026-08-10, accession 0001193125-26-342488.Report this figure154Long-term debt, Q1 FY2026, at 2026-03-31$154.0m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2026-05-07, accession 0001193125-26-212063.Report this figure152Long-term debt, Q2 FY2026, at 2026-06-30$151.9m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2026-08-10, accession 0001193125-26-342488.Report this figure
Current portion of debt$m13.8Current portion of debt, Q3 FY2023, at 2023-09-30$13.8m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2023-11-02, accession 0000950170-23-058257.Report this figure13.8Current portion of debt, FY2023, at 2023-12-31$13.8m. XBRL concept us-gaap:LongTermDebtCurrent. 10-K filed 2025-02-27, accession 0000950170-25-029086.Report this figure13.8Current portion of debt, Q1 FY2024, at 2024-03-31$13.8m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2024-05-07, accession 0000950170-24-054539.Report this figure13.8Current portion of debt, Q2 FY2024, at 2024-06-30$13.8m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2024-08-05, accession 0000950170-24-090808.Report this figure13.8Current portion of debt, Q3 FY2024, at 2024-09-30$13.8m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2024-11-07, accession 0000950170-24-123385.Report this figure13.8Current portion of debt, FY2024, at 2024-12-31$13.8m. XBRL concept us-gaap:LongTermDebtCurrent. 10-K filed 2026-02-26, accession 0001193125-26-076782.Report this figure8.8Current portion of debt, Q1 FY2025, at 2025-03-31$8.8m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2025-05-08, accession 0000950170-25-067044.Report this figure8.8Current portion of debt, Q2 FY2025, at 2025-06-30$8.8m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2025-08-07, accession 0000950170-25-105071.Report this figure8.8Current portion of debt, Q3 FY2025, at 2025-09-30$8.8m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2025-11-06, accession 0001193125-25-269681.Report this figure8.8Current portion of debt, FY2025, at 2025-12-31$8.8m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2026-08-10, accession 0001193125-26-342488.Report this figure8.8Current portion of debt, Q1 FY2026, at 2026-03-31$8.8m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2026-05-07, accession 0001193125-26-212063.Report this figure8.8Current portion of debt, Q2 FY2026, at 2026-06-30$8.8m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2026-08-10, accession 0001193125-26-342488.Report this figure
Shareholders' equity$m1,203Shareholders' equity, Q3 FY2023, at 2023-09-30$1.20bn. XBRL concept us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest. 10-Q filed 2023-11-02, accession 0000950170-23-058257.Report this figure1,199Shareholders' equity, FY2023, at 2023-12-31$1.20bn. XBRL concept us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest. 10-K filed 2025-02-27, accession 0000950170-25-029086.Report this figure1,195Shareholders' equity, Q1 FY2024, at 2024-03-31$1.20bn. XBRL concept us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest. 10-Q filed 2024-05-07, accession 0000950170-24-054539.Report this figure886Shareholders' equity, Q2 FY2024, at 2024-06-30$886.3m. XBRL concept us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest. 10-Q filed 2024-08-05, accession 0000950170-24-090808.Report this figure696Shareholders' equity, Q3 FY2024, at 2024-09-30$695.6m. XBRL concept us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest. 10-Q filed 2024-11-07, accession 0000950170-24-123385.Report this figure607Shareholders' equity, FY2024, at 2024-12-31$607.2m. XBRL concept us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest. 10-K filed 2026-02-26, accession 0001193125-26-076782.Report this figure436Shareholders' equity, Q1 FY2025, at 2025-03-31$435.9m. XBRL concept us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest. 10-Q filed 2025-05-08, accession 0000950170-25-067044.Report this figure411Shareholders' equity, Q2 FY2025, at 2025-06-30$411.2m. XBRL concept us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest. 10-Q filed 2025-08-07, accession 0000950170-25-105071.Report this figure390Shareholders' equity, Q3 FY2025, at 2025-09-30$389.7m. XBRL concept us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest. 10-Q filed 2025-11-06, accession 0001193125-25-269681.Report this figure379Shareholders' equity, FY2025, at 2025-12-31$379.0m. XBRL concept us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest. 10-Q filed 2026-08-10, accession 0001193125-26-342488.Report this figure191Shareholders' equity, Q1 FY2026, at 2026-03-31$190.7m. XBRL concept us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest. 10-Q filed 2026-05-07, accession 0001193125-26-212063.Report this figure188Shareholders' equity, Q2 FY2026, at 2026-06-30$187.9m. XBRL concept us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest. 10-Q filed 2026-08-10, accession 0001193125-26-342488.Report this figure

Cash flow

Operating cash flow$11.5m, Q2 FY2026
Capital expenditure$2.9m, Q2 FY2026
Share repurchases$0, Q2 FY2026
Definitive Healthcare Corp., cash flow, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m9.5Operating cash flow, Q3 FY2023, three months to 2023-09-30$9.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-07, accession 0000950170-24-123385. Derived: 9-month figure less the 6-month figure.Report this figure4.7Operating cash flow, Q4 FY2023, three months to 2023-12-31$4.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-26, accession 0001193125-26-076782. Derived: 12-month figure less the 9-month figure.Report this figure16.6Operating cash flow, Q1 FY2024, three months to 2024-03-31$16.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-08, accession 0000950170-25-067044.Report this figure14.0Operating cash flow, Q2 FY2024, three months to 2024-06-30$14.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-07, accession 0000950170-25-105071. Derived: 6-month figure less the 3-month figure.Report this figure19.4Operating cash flow, Q3 FY2024, three months to 2024-09-30$19.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-06, accession 0001193125-25-269681. Derived: 9-month figure less the 6-month figure.Report this figure8.1Operating cash flow, Q4 FY2024, three months to 2024-12-31$8.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-26, accession 0001193125-26-076782. Derived: 12-month figure less the 9-month figure.Report this figure26.1Operating cash flow, Q1 FY2025, three months to 2025-03-31$26.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-07, accession 0001193125-26-212063.Report this figure9.3Operating cash flow, Q2 FY2025, three months to 2025-06-30$9.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-10, accession 0001193125-26-342488. Derived: 6-month figure less the 3-month figure.Report this figure15.7Operating cash flow, Q3 FY2025, three months to 2025-09-30$15.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-06, accession 0001193125-25-269681. Derived: 9-month figure less the 6-month figure.Report this figure2.7Operating cash flow, Q4 FY2025, three months to 2025-12-31$2.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-26, accession 0001193125-26-076782. Derived: 12-month figure less the 9-month figure.Report this figure11.6Operating cash flow, Q1 FY2026, three months to 2026-03-31$11.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-07, accession 0001193125-26-212063.Report this figure11.5Operating cash flow, Q2 FY2026, three months to 2026-06-30$11.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-10, accession 0001193125-26-342488. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$m0.3Capital expenditure, Q3 FY2023, three months to 2023-09-30$305.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-11-07, accession 0000950170-24-123385. Derived: 9-month figure less the 6-month figure.Report this figure0.6Capital expenditure, Q4 FY2023, three months to 2023-12-31$594.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-26, accession 0001193125-26-076782. Derived: 12-month figure less the 9-month figure.Report this figure0.3Capital expenditure, Q1 FY2024, three months to 2024-03-31$266.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-08, accession 0000950170-25-067044.Report this figure0.4Capital expenditure, Q2 FY2024, three months to 2024-06-30$410.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-08-07, accession 0000950170-25-105071. Derived: 6-month figure less the 3-month figure.Report this figure0.8Capital expenditure, Q3 FY2024, three months to 2024-09-30$767.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-06, accession 0001193125-25-269681. Derived: 9-month figure less the 6-month figure.Report this figure10.9Capital expenditure, Q4 FY2024, three months to 2024-12-31$10.9m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-26, accession 0001193125-26-076782. Derived: 12-month figure less the 9-month figure.Report this figure7.7Capital expenditure, Q1 FY2025, three months to 2025-03-31$7.7m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-07, accession 0001193125-26-212063.Report this figure2.3Capital expenditure, Q2 FY2025, three months to 2025-06-30$2.3m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-10, accession 0001193125-26-342488. Derived: 6-month figure less the 3-month figure.Report this figure2.3Capital expenditure, Q3 FY2025, three months to 2025-09-30$2.3m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-06, accession 0001193125-25-269681. Derived: 9-month figure less the 6-month figure.Report this figure4.4Capital expenditure, Q4 FY2025, three months to 2025-12-31$4.4m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-26, accession 0001193125-26-076782. Derived: 12-month figure less the 9-month figure.Report this figure3.2Capital expenditure, Q1 FY2026, three months to 2026-03-31$3.2m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-07, accession 0001193125-26-212063.Report this figure2.9Capital expenditure, Q2 FY2026, three months to 2026-06-30$2.9m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-10, accession 0001193125-26-342488. Derived: 6-month figure less the 3-month figure.Report this figure
Share repurchases$m0.0Share repurchases, Q3 FY2023, three months to 2023-09-30$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2024-11-07, accession 0000950170-24-123385. Derived: 9-month figure less the 6-month figure.Report this figure0.0Share repurchases, Q4 FY2023, three months to 2023-12-31$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-K filed 2026-02-26, accession 0001193125-26-076782. Derived: 12-month figure less the 9-month figure.Report this figure0.0Share repurchases, Q1 FY2024, three months to 2024-03-31$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2025-05-08, accession 0000950170-25-067044.Report this figure7.0Share repurchases, Q2 FY2024, three months to 2024-06-30$7.0m. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2025-08-07, accession 0000950170-25-105071. Derived: 6-month figure less the 3-month figure.Report this figure8.0Share repurchases, Q3 FY2024, three months to 2024-09-30$8.0m. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2025-11-06, accession 0001193125-25-269681. Derived: 9-month figure less the 6-month figure.Report this figure7.3Share repurchases, Q4 FY2024, three months to 2024-12-31$7.3m. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-K filed 2026-02-26, accession 0001193125-26-076782. Derived: 12-month figure less the 9-month figure.Report this figure21.2Share repurchases, Q1 FY2025, three months to 2025-03-31$21.2m. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2026-05-07, accession 0001193125-26-212063.Report this figure19.1Share repurchases, Q2 FY2025, three months to 2025-06-30$19.1m. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2026-08-10, accession 0001193125-26-342488. Derived: 6-month figure less the 3-month figure.Report this figure9.2Share repurchases, Q3 FY2025, three months to 2025-09-30$9.2m. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2025-11-06, accession 0001193125-25-269681. Derived: 9-month figure less the 6-month figure.Report this figure0.0Share repurchases, Q4 FY2025, three months to 2025-12-31$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-K filed 2026-02-26, accession 0001193125-26-076782. Derived: 12-month figure less the 9-month figure.Report this figure0.0Share repurchases, Q1 FY2026, three months to 2026-03-31$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2026-05-07, accession 0001193125-26-212063.Report this figure0.0Share repurchases, Q2 FY2026, three months to 2026-06-30$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2026-08-10, accession 0001193125-26-342488. Derived: 6-month figure less the 3-month figure.Report this figure

Shares

Diluted shares (weighted)105.81m, Q2 FY2026
Definitive Healthcare Corp., shares, quarterly
Line itemUnitQ4 FY20222022-12-31Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares154Diluted shares (weighted), Q4 FY2022, three months to 2022-12-31154,006,454 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-K/A filed 2023-08-14, accession 0000950170-23-042369.Report this figure108Diluted shares (weighted), Q1 FY2023, three months to 2023-03-31108,234,043 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-07, accession 0000950170-24-054539.Report this figure112Diluted shares (weighted), Q2 FY2023, three months to 2023-06-30111,768,782 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-05, accession 0000950170-24-090808.Report this figure115Diluted shares (weighted), Q3 FY2023, three months to 2023-09-30114,527,514 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-07, accession 0000950170-24-123385.Report this figure117Diluted shares (weighted), Q1 FY2024, three months to 2024-03-31117,433,520 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-08, accession 0000950170-25-067044.Report this figure118Diluted shares (weighted), Q2 FY2024, three months to 2024-06-30117,750,392 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-07, accession 0000950170-25-105071.Report this figure116Diluted shares (weighted), Q3 FY2024, three months to 2024-09-30116,382,021 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-06, accession 0001193125-25-269681.Report this figure113Diluted shares (weighted), Q1 FY2025, three months to 2025-03-31112,782,505 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-07, accession 0001193125-26-212063.Report this figure107Diluted shares (weighted), Q2 FY2025, three months to 2025-06-30106,815,740 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-10, accession 0001193125-26-342488.Report this figure104Diluted shares (weighted), Q3 FY2025, three months to 2025-09-30103,783,012 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-06, accession 0001193125-25-269681.Report this figure105Diluted shares (weighted), Q1 FY2026, three months to 2026-03-31104,675,068 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-07, accession 0001193125-26-212063.Report this figure106Diluted shares (weighted), Q2 FY2026, three months to 2026-06-30105,810,516 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-10, accession 0001193125-26-342488.Report this figure

Shares outstanding: 106.74mShares outstanding, period not labelled, at 2026-08-06106,744,713 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-10, accession 0001193125-26-342488.Report this figure at Aug 6, 2026, from the cover of the 10-Q filed Aug 10, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:49 ET. Listed shows no prices and gives no investment advice.